Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein, Inc. (NASDAQ: HSIC) showcased a diverse array of products and services at the 2022 Chicago Midwinter Dental Meeting, emphasizing advancements in dental practice performance. Key highlights included the launch of the Medit i700 intraoral scanner and Septodont BioRoot Flow root canal sealer. The company also introduced Jarvis for Private Practices, enhancing practice analytics. Visitors engaged with leaders from multiple renowned dental product companies while exploring solutions aimed at optimizing workflow efficiency. The meeting, held from February 24-26, 2022, provided a platform for networking and learning innovations in oral health.
Henry Schein, Inc. (NASDAQ: HSIC) has launched a virtual program titled “Optimism and Opportunities in Oral Health,” coinciding with the Chicago Midwinter Dental Meeting. This on-demand program features discussions with ASDA leaders and Henry Schein executives, focusing on the dental profession's evolution. CEO Stanley Bergman emphasized the importance of sharing insights for the advancement of dentistry. This initiative reflects the company's commitment to oral health as part of overall healthcare.
Zahn Dental, the dental laboratory business of Henry Schein, has committed $150,000 to Feeding America to aid communities facing food insecurity, particularly seniors. This contribution aims to enhance access to nutrition and combat malnutrition among elderly individuals, who often suffer from chronic conditions affecting their dietary needs. Zahn's supplier partners will also support this initiative. Feeding America highlights that over 38 million people in the U.S. face food insecurity, an issue worsened by the pandemic. This partnership aligns with Zahn's mission to link oral health with overall well-being.
Henry Schein reported fourth-quarter 2021 net sales of $3.3 billion, a 5.2% increase year-over-year. GAAP diluted EPS from continuing operations rose to $1.05, up from $0.99 a year earlier. Non-GAAP diluted EPS also increased to $1.07 from $1.00.
The company projects 2022 GAAP diluted EPS between $4.75 and $4.91, reflecting 7% to 10% growth from 2021. Global dental sales reached $2.0 billion for the quarter, a 9.4% rise, while medical sales declined by 3.2%. The company continues to focus on operational improvements and technology services.
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in two virtual investor events in February 2022. The events include the Baird 2022 Sustainability Conference on February 23, 2022, at 2:20 p.m. Eastern and the Jefferies 2022 Dental Summit on February 24, 2022, at 1:00 p.m. Eastern. The Baird conference will be available for live webcast, with replays accessible on their website. Henry Schein reported $10.1 billion in sales for 2020, highlighting its significant impact in the healthcare industry.
Henry Schein, Inc. (NASDAQ: HSIC) is set to host its inaugural in-person THRIVE LIVE™ event from April 7-9 at the Bellagio Hotel & Casino in Las Vegas, NV. This premier educational gathering will focus on the latest in dental technology, offering clinicians and their teams opportunities to learn from industry leaders and network with peers. The event will also integrate the Business of Dentistry conference, enhancing the educational value for attendees. The initiative underscores Henry Schein's commitment to equipping dental professionals with vital knowledge for effective practice management.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
